BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Sunbird Bio Secures $14M in New Funding from Eli Lilly and EDBI to Advance Blood-Based Diagnostic Technology for Neurological Disorders

Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI – – Sunbird will use additional funds to furth...

October 17, 2024 | News

Tencent Invests US$30 Million in Hong Kong’s Insighta, Valuing the Early Cancer Detection Company at US$200 Million

Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, announced that Tencent has made a strategic US$30 million&n...

October 16, 2024 | News

ShiraTronics Raises $66M in Series B to Advance Innovative Neuromodulation Therapy for Chronic Migraine Patients

Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Atta...

October 10, 2024 | News

SK bioscience Invests USD 3 Million in FinaBio to Enhance Next-Generation Conjugate Vaccine Development

SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bio...

October 08, 2024 | News

Biocon Biologics Secures USD 800 Million Bond Issuance, Largest High-Yield Debut from India in a Decade

USD 800 million (INR 66,763 million) Senior Secured Notes (“Bonds”) The Largest High Yield Debut USD Bond Issuance from India in the Last 10 Y...

October 03, 2024 | News

Thermo Fisher Expands North American Oral Drug Development Capabilities with $22M Investment in Cincinnati and Bend Sites

Additions to sites in Cincinnati, Ohio, and Bend, Ore. broaden early development capabilities to help accelerate pre-clinical oral drug product innovation ...

September 27, 2024 | News

Full-Life Technologies Secures $571.5M Licensing Deal with SK Biopharmaceuticals for Anti-Cancer Radiopharmaceutical FL-091

Full-Life Technologies seals $571.5 million agreement with SK Biopharmaceuticals to license and further develop Full-Life's 'FL-091' ra...

September 19, 2024 | News

RSSL Introduces £700K Laboratory for Advanced 3D Imaging & Metrology Services

RSSL, a leading food and life science contract research organisation, has announced the opening of a new laboratory providing a suite of advanced 3D ...

September 19, 2024 | News

Bambusa Therapeutics Secures $15M in Series Seed Funding to Advance Bispecific Antibody Pipeline

Bambusa Therapeutics Inc., a biotechnology company focused on developing bispecific antibodies for the treatment of immunological and inflammatory (I&I...

September 10, 2024 | News

Arsenal Biosciences Closes $325 Million Series C Funding to Advance Next-Gen CAR T-Cell Therapies for Solid Tumors

Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid t...

September 05, 2024 | News

LOTTE Holdings Launches New CVC to Propel Innovations in Biopharmaceuticals and Next-Generation Modalities

LOTTE Holdings Co., Ltd. ("LOTTE Holdings") is pleased to announce the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital ("...

August 29, 2024 | News

Finnish Biotech NADMED Secures €3.5M to Transform Vitamin B3 Testing with Groundbreaking NAD Measurement Technology

Finnish biotech company NADMED has developed the first test to measure all four bodily forms of vitamin B3, called NADs, and glutathiones directly from fre...

August 23, 2024 | News

Boston Immune Technologies and Therapeutics Secures Strategic Agreement with Otsuka's MSRD and $4M NIH/NCI Grant for Advancing Antibody Development

Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage developer of novel tumor necrosis factor superfamily receptor (TNFSR) antagonist...

August 19, 2024 | News

Rona Therapeutics Secures $35 Million Series A+ Financing to Advance siRNA Programs

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 M...

July 22, 2024 | News

Stay Connected